Scarring alopecia as an unexpected consequence of immune checkpoint inhibition

By afschroeder • June 18, 2025

Kokikian N, Tarabay J, Goh C. Scarring alopecia as an unexpected consequence of immune checkpoint inhibition. JAAD Case Rep. 2025 May 8;61:1-6. doi: 10.1016/j.jdcr.2025.04.007. PMID: 40530179; PMCID: PMC12173679.

Tags: Alopecia, Dermatology, immune checkpoint inhibitor, PD-1 inhibitor, pembrolizumab, Publications, scarring alopecia

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

Mayo T, Silverberg JI, Armstrong A, Guttman-Yassky E, Blauvelt A, Esdaile B, Kabashima K, Gooderham M, Kircik L, Schneider S, Bennike N, von Eyben R,[...]

Bidirectional risk between autoimmune blistering diseases and posttraumatic stress disorder

Kasperkiewicz M, Ludwig RJ, Curman P. Bidirectional risk between autoimmune blistering diseases and posttraumatic stress disorder. J Eur Acad Dermatol Venereol. 2025 Oct 17. doi:[...]

Biologic Therapies For Dermatologic Emergencies: A Comprehensive Review

Modanlo N, Cheng K, Nguyen MO, Truong A. Biologic Therapies For Dermatologic Emergencies: A Comprehensive Review. J Am Acad Dermatol. 2025 Oct 17:S0190-9622(25)03025-7. doi: 10.1016/j.jaad.2025.10.055.[...]